Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2023 09:15 ET | Source: CytoSorbents

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

CytoSorbents Strengthens Balance Sheet with $10.3M Registered Direct Offering. Insiders invest $435,000
November 09, 2023 16:15 ET | Source: CytoSorbents

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
October 27, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
October 05, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents to Present at the 8th Annual Dawson James Conference

CytoSorbents to Highlight Company Progress at Dawson James Small Cap Investor Growth Conference
September 27, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress
September 19, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...
September 11, 2023 11:32 ET | Source: CytoSorbents

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation

PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
September 01, 2023 16:43 ET | Source: CytoSorbents

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico

PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
August 31, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil

PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...
August 01, 2023 16:15 ET | Source: CytoSorbents

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results

Q2 2023 Total Revenue was $9.4 million, an 11% increase from $8.5 million in Q2 2022. Product sales rose 10% to $8.1 million vs $7.3 million in Q2 2022. Product gross margins grew 700 basis points...